Integra LifeSciences (IART) vs PROCEPT BioRobotics (PRCT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Integra LifeSciences (IART) has outperformed PROCEPT BioRobotics (PRCT) over the past year, losing 9.9% versus a loss of 48.3%. Over five years, PRCT leads with a -58.9% price change compared with -80.8% for IART. Integra LifeSciences is the larger company by market cap ($1.04 billion vs $1.02 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IART | PRCT |
|---|---|---|
| Share price | $13.41 | $17.90 |
| Market cap | $1.04B | $1.02B |
| 1-day change | +3.15% | -0.06% |
| YTD return | +4.67% | -43.07% |
| 1-year return | -9.91% | -48.25% |
| 5-year return | -80.79% | -58.89% |
| Forward P/E | 5.16 | — |
| EPS (TTM) | $-0.09 | $-1.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $20.49 | $38.11 |
| 52-week low | $8.70 | $16.67 |
| Distance from 52-week high | -34.55% | -53.03% |
| Analyst consensus | hold | hold |
| Avg. price target upside | +37.06% | +25.25% |
| Average volume | 908.43K | 1.44M |
| Shares outstanding | 77.77M | 56.92M |
| Employees | 4,427 | 888 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IART has outperformed PRCT by 38.3 percentage points over the past year.
About Integra LifeSciences
IART stock →Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.
Health Care · Medical/Dental Instruments · 4,427 employees
About PROCEPT BioRobotics
PRCT stock →PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia.
Health Care · Medical/Dental Instruments · 888 employees
IART vs PRCT FAQ
Which is bigger, Integra LifeSciences or PROCEPT BioRobotics?
Integra LifeSciences (IART) is larger, with a market capitalization of $1.04B compared with $1.02B for PROCEPT BioRobotics (PRCT).
Which stock has performed better over the past year, IART or PRCT?
IART returned -9.91% over the past 12 months, compared with -48.25% for PRCT (price return, excluding dividends). Past performance does not predict future results.
Are Integra LifeSciences and PROCEPT BioRobotics in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.